Combined effects of genotype and childhood adversity shape variability of DNA methylation across age.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 19 11 2020
accepted: 04 12 2020
revised: 02 12 2020
entrez: 2 2 2021
pubmed: 3 2 2021
medline: 29 6 2021
Statut: epublish

Résumé

Lasting effects of adversity, such as exposure to childhood adversity (CA) on disease risk, may be embedded via epigenetic mechanisms but findings from human studies investigating the main effects of such exposure on epigenetic measures, including DNA methylation (DNAm), are inconsistent. Studies in perinatal tissues indicate that variability of DNAm at birth is best explained by the joint effects of genotype and prenatal environment. Here, we extend these analyses to postnatal stressors. We investigated the contribution of CA, cis genotype (G), and their additive (G + CA) and interactive (G × CA) effects to DNAm variability in blood or saliva from five independent cohorts with a total sample size of 1074 ranging in age from childhood to late adulthood. Of these, 541 were exposed to CA, which was assessed retrospectively using self-reports or verified through social services and registries. For the majority of sites (over 50%) in the adult cohorts, variability in DNAm was best explained by G + CA or G × CA but almost never by CA alone. Across ages and tissues, 1672 DNAm sites showed consistency of the best model in all five cohorts, with G × CA interactions explaining most variance. The consistent G × CA sites mapped to genes enriched in brain-specific transcripts and Gene Ontology terms related to development and synaptic function. Interaction of CA with genotypes showed the strongest contribution to DNAm variability, with stable effects across cohorts in functionally relevant genes. This underscores the importance of including genotype in studies investigating the impact of environmental factors on epigenetic marks.

Identifiants

pubmed: 33526782
doi: 10.1038/s41398-020-01147-z
pii: 10.1038/s41398-020-01147-z
pmc: PMC7851167
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Subventions

Organisme : NIMH NIH HHS
ID : U19 MH069056
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH071537
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD100902
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000039
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH080880
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025008
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH077083
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Références

Trials. 2012 Jul 09;13:106
pubmed: 22776534
Genome Res. 2014 Jul;24(7):1064-74
pubmed: 24709820
G3 (Bethesda). 2016 Apr 07;6(4):973-86
pubmed: 26888867
Nat Commun. 2019 Jun 11;10(1):2548
pubmed: 31186427
J Trauma Stress. 2008 Apr;21(2):218-22
pubmed: 18404649
Child Dev. 2013 Jan-Feb;84(1):49-57
pubmed: 22880724
Transl Psychiatry. 2014 Sep 23;4:e448
pubmed: 25247593
Nat Methods. 2015 Oct;12(10):931-4
pubmed: 26301843
BMC Genomics. 2014 Feb 21;15:145
pubmed: 24555763
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Psychol Bull. 2004 Jul;130(4):601-30
pubmed: 15250815
Biol Psychiatry. 2017 Dec 15;82(12):866-874
pubmed: 28793974
PLoS One. 2013 May 17;8(5):e63812
pubmed: 23691101
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Nature. 2013 Aug 22;500(7463):477-81
pubmed: 23925113
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Nature. 2010 Oct 28;467(7319):1061-73
pubmed: 20981092
Clin Epigenetics. 2014 Feb 03;6(1):4
pubmed: 24485148
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
Genome Biol. 2018 May 23;19(1):61
pubmed: 29792225
J Affect Disord. 2011 Nov;134(1-3):160-7
pubmed: 21665286
Nat Genet. 2017 Jan;49(1):131-138
pubmed: 27918535
Nat Biotechnol. 2010 Oct;28(10):1057-68
pubmed: 20944598
Diabetologia. 2006 Dec;49(12):2853-8
pubmed: 17096117
Elife. 2013 Jun 04;2:e00523
pubmed: 23755361
Am J Public Health. 2001 May;91(5):753-60
pubmed: 11344883
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Int J Epidemiol. 2018 Aug 1;47(4):1120-1130
pubmed: 29860346
Psychosom Med. 2008 Apr;70(3):306-13
pubmed: 18378874
PLoS Genet. 2010 May 13;6(5):e1000952
pubmed: 20485568
Am J Psychiatry. 2018 Jun 1;175(6):517-529
pubmed: 29325449
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):505-14
pubmed: 19892208
N Engl J Med. 2005 Oct 27;353(17):1802-9
pubmed: 16251536
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
JAMA Pediatr. 2017 Dec 1;171(12):1168-1175
pubmed: 29084329
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):36-44
pubmed: 25355443
Eur Child Adolesc Psychiatry. 2020 Oct;29(10):1329-1338
pubmed: 30968208
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Am J Psychiatry. 1994 Aug;151(8):1132-6
pubmed: 8037246
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
Psychoneuroendocrinology. 2010 Jun;35(5):758-67
pubmed: 19963324
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Genome Biol. 2015 Dec 17;16:266
pubmed: 26673150
Genome Biol. 2016 Mar 31;17:61
pubmed: 27036880
Child Maltreat. 2019 Nov;24(4):458-465
pubmed: 31495193
Int J Epidemiol. 2012 Feb;41(1):200-9
pubmed: 22422453
Nat Rev Genet. 2019 Aug;20(8):437-455
pubmed: 31086298
Neurosci Biobehav Rev. 2020 May;112:392-409
pubmed: 32081689

Auteurs

Darina Czamara (D)

Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany. darina@psych.mpg.de.

Elleke Tissink (E)

Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, 1081 HV, Amsterdam, The Netherlands.

Johanna Tuhkanen (J)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, 00014, Helsinki, Finland.

Jade Martins (J)

Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany.

Yvonne Awaloff (Y)

Sopra Steria, 80804, Munich, Germany.

Amanda J Drake (AJ)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.

Batbayar Khulan (B)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.

Aarno Palotie (A)

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.

Sibylle M Winter (SM)

Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Campus Virchow, 13353, Berlin, Germany.

Charles B Nemeroff (CB)

Department of Psychiatry, Dell Medical School, University of Texas at Austin, 1601 Trinity St, Austin, TX, 78712, USA.

W Edward Craighead (WE)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, Atlanta, GA, 30329, USA.

Boadie W Dunlop (BW)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, Atlanta, GA, 30329, USA.

Helen S Mayberg (HS)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, Atlanta, GA, 30329, USA.
Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy PI, New York, NY, 10029, USA.

Becky Kinkead (B)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, Atlanta, GA, 30329, USA.

Sanjay J Mathew (SJ)

Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine Mental Health Care Line, Michael E. Debakey VA Medical Center, Houston, TX, USA.

Dan V Iosifescu (DV)

Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy PI, New York, NY, 10029, USA.
NYU School of Medicine and Nathan Kline Institute, New York, NY, USA.

Thomas C Neylan (TC)

Departments of Psychiatry and Neurology, University of California, San Francisco, CA, USA.

Christine M Heim (CM)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Institute of Medical Psychology, Luisenstraße 57, 10117, Berlin, Germany.

Jari Lahti (J)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, 00014, Helsinki, Finland.
Turku Institute for Advanced Studies, University of Turku, 20500, Turku, Finland.

Johan G Eriksson (JG)

Department of General Practice and Primary Health Care, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
Folkhälsan Research Center, 00250, Helsinki, Finland.
Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Singapore Institute for Clinical Sciences, Singapore, Singapore.

Katri Räikkönen (K)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, 00014, Helsinki, Finland.

Kerry J Ressler (KJ)

Mailman Research Center, 115 Mill St., Mailstop 339, Belmont, MA, 02478, USA.

Nadine Provençal (N)

Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, Canada.
BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Elisabeth B Binder (EB)

Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany. binder@psych.mpg.de.
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, Atlanta, GA, 30329, USA. binder@psych.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH